跳至主要内容
临床试验/NCT03899922
NCT03899922已完成不适用

Monitoring Drug-induced Uveitis

Groupe Hospitalier Pitie-Salpetriere1 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2019年4月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
1,000
试验地点
1
主要终点
Eye toxicities of drugs Identification and report of cases of uevitis associated with drugs

研究概览

简要总结

Several drugs and chemotherapies seem to induce uveitis. This study investigates reports of uveitis, including the International classification of disease ICD-10 for treatments in the World Health Organization (WHO) global Individual Case Safety Report (ICSR) database (VigiBase).

详细描述

Several drugs and chemotherapies seem to have an impact on the eyes and are responsible of uveitis. Those are poorly described, due to the modification of the pharmacopeia, and the recent recognition of several of these adverse events. This study investigates the main characteristics of patients affected by uveitis side effect imputed to drugs. A causality assessment according to the WHO-UMC (World Health Organization - Uppsala Monitoring Center) is systematically applied.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Case reported in the WHO's pharmacovigilance database till 01/04/2019

排除标准

  • Chronology not compatible between the drug and the toxicity

研究组 & 干预措施

Uveitis induced by drugs and chemotherapies

Case reported in the World Health Organization (WHO) of uveitis of patient treated by a drug, with a chronology compatible with the drug toxicity

干预措施: Drugs inducing uveitis (Drug)

结局指标

主要结局

Eye toxicities of drugs Identification and report of cases of uevitis associated with drugs

时间窗: to 01/04/2019

Case reported in the World Health Organization (WHO) database of individual safety case reports

次要结局

  • Causality assessment of reported uveitis according to the WHO system(to 01/04/2019)
  • Duration of treatment when uveitis happen (role of cumulative dose)(to 01/04/2019)
  • All relevants statisticals associations between type of uveitis and the category of drug(to 01/04/2019)
  • All relevants statisticals associations between other concomittants immune related adverse events and uveitis induced by drugs(to 01/04/2019)
  • All relevants statisticals associations between drug-drug interactions and adverse events(to 01/04/2019)
  • All relevants statisticals associations between pathologies (cancer) for which the incriminated drugs have been prescribed, and occurence of uveitis(to 01/04/2019)
  • All relevants statisticals associations between characteristics of the population and occurence of uveitis adverse event(to 01/04/2019)

研究者

发起方
Groupe Hospitalier Pitie-Salpetriere
申办方类型
Other
责任方
Principal Investigator
主要研究者

Joe Elie Salem

Assistant director, clinical investigation center Paris Est

Groupe Hospitalier Pitie-Salpetriere

研究点 (1)

Loading locations...

相似试验